Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07524101) titled 'Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD' on April 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Yonsei University
Condition:
Renal Insufficiency
Atherosclerosis
Dyslipidemia
Hypercholesterolemia
Cardiovascular Diseases
Intervention:
Drug: Moderate-intensity statin and ezetimibe combination therapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 1, 2026
Target Sample Size: 1952
To know more, visit https://clinicaltrials.go...